Investing Profile

Hakan Goker

InvestorVC

Managing Director at M Ventures (Merck)

m-ventures.com/enAmsterdam, Netherlands

Your Intro Paths to Hakan Goker

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Hakan Goker on

Current Investing Position

M Ventures (Merck) Managing Director

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Current Fund Size

€600M

Hakan Goker is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Series B)BioTech (Seed)Pharmaceuticals (Series B)BioTech (Series A)Pharmaceuticals (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)Digital Health (Series B)Therapeutics (Seed)Therapeutics (Series B)Therapeutics (Series A)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Hakan Goker's Investments On Record (13)

Company	StageDateRound Size	Total Raised
Storm Therapeutics	Series CApr 2026$56M Series BDec 2022$30M Series AMay 2019$18M Series AJun 2016$16M	$130M
Co-investors: Sakae Asanuma (Taiho Ventures), Bruno Montanari (Seroba Life Sciences), Robert Tansley (Cambridge Innovation Capital)
Artios Pharma	Series DNov 2025$120M Series CJul 2021$150M Series ASep 2016$33M	$380M
Co-investors: Raphael Wisniewski (Andera Partners), Barbara Dalton (Pfizer Venture Investments), René Kuijten (EQT Life Sciences), Florian Müllershausen (Novartis Venture Fund), Nikola Trbovic (Pfizer Venture Investments), Jake Simson (RA Capital)
Actithera	Series AJul 2025$76M	$76M
Co-investors: Therese Liechtenstein (MDC Ventures (formerly KBS Ventures)), Noga Yerushalmi (MDC Ventures (formerly KBS Ventures))
ReproNovo	Series AMay 2025$65M	$65M
TRIMTECH Therapeutics	SeedMar 2025$31M	$31M
Co-investors: Michael Anstey (Cambridge Innovation Capital), Jeffrey Moore (MP Healthcare Venture Management), Laurence Barker (SV Health Investors)
Asceneuron	Series CJul 2024$100M Series ASep 2015$31M	$130M
Co-investors: Henrijette Richter (Soffinova Partners), Philip Scheltens (EQT Life Sciences)
iOnctura	Series BJun 2024$86M Series AJul 2020$6M Series AJan 2020$17M SeedJun 2017	$110M
Co-investors: Keno Gutierrez (BGV (BioGeneration Ventures)), Thijs Cohen Tervaert (INKEF Capital), Roel Bulthuis (INKEF Capital), Fiona MacLaughlin (Johnson & Johnson Innovation)
Nouscom	Series CNov 2023$73M	$140M
Co-investors: Scott Rocklage (5am Ventures), Guido Magni (Versant Ventures), Joachim Rothe (EQT Life Sciences), Genghis Lloyd-Harris (Abingworth), Sofia Ioannidou (Andera Partners)